Using PICO Methodology to Answer Questions About Smoking in COPD Patients
The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i) moderate-qua...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22844
- Acceso en línea:
- https://doi.org/10.1016/j.arbres.2017.04.012
https://repository.urosario.edu.co/handle/10336/22844
- Palabra clave:
- Article
Chronic obstructive lung disease
Counseling
High risk patient
Hospital discharge
Hospitalization
Human
Smoking
Smoking cessation
Spirometry
Age
Health economics
High risk population
Smoking habit
Chronic obstructive lung disease
Clinical trial (topic)
Cost benefit analysis
Drug therapy
Economics
Evidence based medicine
Motivation
Pathophysiology
Procedures
Psychology
Questionnaire
Randomized controlled trial (topic)
Smoking
Therapy
Amfebutamone
Biological marker
Nicotine
Nicotinic agent
Varenicline
Biomarkers
Bupropion
Clinical Trials as Topic
Cost-Benefit Analysis
Counseling
Evidence-Based Medicine
Humans
Motivation
Nicotine
Nicotinic Agonists
Randomized Controlled Trials as Topic
Smoking
Smoking Cessation
Spirometry
Surveys and Questionnaires
Varenicline
Chronic obstructive pulmonary disease
Smoking
Spirometry
Treatment
Chronic Obstructive
Pulmonary Disease
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_b08d3267bb43801e02d637e08c4030d2 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/22844 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
bf2e764c-74a1-4eab-8320-5fefc2f5870d-11dcf4a75-7f4c-4f79-b80d-c94d7e003b20-12165c876-9d73-4a82-b63e-8d1b985152cf-1d334f774-9fe5-4230-9af9-3ff7f58b2193-198182fc3-ff8b-46be-bb79-4ae142fc6e78-1be3b31e1-eedd-4eb9-86e3-6d2997f9ddce-149e92ebc-d75c-41cc-b642-f08bb284b7b7-1c76f13e5-0cf9-48e1-89e2-96e31a259cbb-1fb43f270-0c43-48e9-b302-b7fe14d7f7e5-122c4c36f-b086-4de1-be37-32625e55e270-134318d1b-d3e2-4948-ade5-df096c2e9f5d-152f38d2c-99b8-4056-923d-ebfb5ea4a87c-186cf804c-49ed-4551-b199-89afa88460ff-1896214f8-a539-44cd-b31f-e9fffc2697d9-1f057f8a7-f594-4591-b88b-286c7ce5322a-13251e019-5c56-401b-abde-48469007729f-12020-05-25T23:58:21Z2020-05-25T23:58:21Z2017The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i) moderate-quality evidence and strong recommendation for performing spirometry in COPD patients and in smokers with a high risk of developing the disease, as a motivational tool (particularly for showing evidence of lung age), a diagnostic tool, and for active case-finding; (ii) high-quality evidence and strong recommendation for using intensive dedicated behavioral counselling and drug treatment for helping COPD patients to stop smoking; (iii) high-quality evidence and strong recommendation for initiating interventions for helping COPD patients to stop smoking during hospitalization with improvement when the intervention is prolonged after discharge, and (iv) high-quality evidence and strong recommendation for funding treatment of smoking in COPD patients, in view of the impact on health and health economics. © 2017 SEPARapplication/pdfhttps://doi.org/10.1016/j.arbres.2017.04.0123002896https://repository.urosario.edu.co/handle/10336/22844engElsevier Doyma628No. 11622Archivos de BronconeumologiaVol. 53Archivos de Bronconeumologia, ISSN:3002896, Vol.53, No.11 (2017); pp. 622-628https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044788291&doi=10.1016%2fj.arbres.2017.04.012&partnerID=40&md5=1a73c119424c3fc87652814daeea1b5eAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURArticleChronic obstructive lung diseaseCounselingHigh risk patientHospital dischargeHospitalizationHumanSmokingSmoking cessationSpirometryAgeHealth economicsHigh risk populationSmoking habitChronic obstructive lung diseaseClinical trial (topic)Cost benefit analysisDrug therapyEconomicsEvidence based medicineMotivationPathophysiologyProceduresPsychologyQuestionnaireRandomized controlled trial (topic)SmokingTherapyAmfebutamoneBiological markerNicotineNicotinic agentVareniclineBiomarkersBupropionClinical Trials as TopicCost-Benefit AnalysisCounselingEvidence-Based MedicineHumansMotivationNicotineNicotinic AgonistsRandomized Controlled Trials as TopicSmokingSmoking CessationSpirometrySurveys and QuestionnairesVareniclineChronic obstructive pulmonary diseaseSmokingSpirometryTreatmentChronic ObstructivePulmonary DiseaseUsing PICO Methodology to Answer Questions About Smoking in COPD PatientsPreguntas y respuestas relacionadas con tabaquismo en pacientes con EPOC. Aplicación de metodología con formato PICOarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Jiménez Ruiz C.A.Buljubasich D.Riesco Miranda J.A.Acuña Izcaray A.de Granda Orive J.I.Chatkin J.M.Zabert G.Guerreros Benavides A.Paez Espinel N.Noé V.Sánchez-Angarita E.Núñez-Sánchez I.Sansores R.H.Casas A.Palomar Lever A.Alfageme Michavila I.10336/22844oai:repository.urosario.edu.co:10336/228442022-05-02 07:37:20.799559https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients |
dc.title.TranslatedTitle.spa.fl_str_mv |
Preguntas y respuestas relacionadas con tabaquismo en pacientes con EPOC. Aplicación de metodología con formato PICO |
title |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients |
spellingShingle |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients Article Chronic obstructive lung disease Counseling High risk patient Hospital discharge Hospitalization Human Smoking Smoking cessation Spirometry Age Health economics High risk population Smoking habit Chronic obstructive lung disease Clinical trial (topic) Cost benefit analysis Drug therapy Economics Evidence based medicine Motivation Pathophysiology Procedures Psychology Questionnaire Randomized controlled trial (topic) Smoking Therapy Amfebutamone Biological marker Nicotine Nicotinic agent Varenicline Biomarkers Bupropion Clinical Trials as Topic Cost-Benefit Analysis Counseling Evidence-Based Medicine Humans Motivation Nicotine Nicotinic Agonists Randomized Controlled Trials as Topic Smoking Smoking Cessation Spirometry Surveys and Questionnaires Varenicline Chronic obstructive pulmonary disease Smoking Spirometry Treatment Chronic Obstructive Pulmonary Disease |
title_short |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients |
title_full |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients |
title_fullStr |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients |
title_full_unstemmed |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients |
title_sort |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients |
dc.subject.keyword.spa.fl_str_mv |
Article Chronic obstructive lung disease Counseling High risk patient Hospital discharge Hospitalization Human Smoking Smoking cessation Spirometry Age Health economics High risk population Smoking habit Chronic obstructive lung disease Clinical trial (topic) Cost benefit analysis Drug therapy Economics Evidence based medicine Motivation Pathophysiology Procedures Psychology Questionnaire Randomized controlled trial (topic) Smoking Therapy Amfebutamone Biological marker Nicotine Nicotinic agent Varenicline Biomarkers Bupropion Clinical Trials as Topic Cost-Benefit Analysis Counseling Evidence-Based Medicine Humans Motivation Nicotine Nicotinic Agonists Randomized Controlled Trials as Topic Smoking Smoking Cessation Spirometry Surveys and Questionnaires Varenicline Chronic obstructive pulmonary disease Smoking Spirometry Treatment |
topic |
Article Chronic obstructive lung disease Counseling High risk patient Hospital discharge Hospitalization Human Smoking Smoking cessation Spirometry Age Health economics High risk population Smoking habit Chronic obstructive lung disease Clinical trial (topic) Cost benefit analysis Drug therapy Economics Evidence based medicine Motivation Pathophysiology Procedures Psychology Questionnaire Randomized controlled trial (topic) Smoking Therapy Amfebutamone Biological marker Nicotine Nicotinic agent Varenicline Biomarkers Bupropion Clinical Trials as Topic Cost-Benefit Analysis Counseling Evidence-Based Medicine Humans Motivation Nicotine Nicotinic Agonists Randomized Controlled Trials as Topic Smoking Smoking Cessation Spirometry Surveys and Questionnaires Varenicline Chronic obstructive pulmonary disease Smoking Spirometry Treatment Chronic Obstructive Pulmonary Disease |
dc.subject.keyword.eng.fl_str_mv |
Chronic Obstructive Pulmonary Disease |
description |
The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i) moderate-quality evidence and strong recommendation for performing spirometry in COPD patients and in smokers with a high risk of developing the disease, as a motivational tool (particularly for showing evidence of lung age), a diagnostic tool, and for active case-finding; (ii) high-quality evidence and strong recommendation for using intensive dedicated behavioral counselling and drug treatment for helping COPD patients to stop smoking; (iii) high-quality evidence and strong recommendation for initiating interventions for helping COPD patients to stop smoking during hospitalization with improvement when the intervention is prolonged after discharge, and (iv) high-quality evidence and strong recommendation for funding treatment of smoking in COPD patients, in view of the impact on health and health economics. © 2017 SEPAR |
publishDate |
2017 |
dc.date.created.spa.fl_str_mv |
2017 |
dc.date.accessioned.none.fl_str_mv |
2020-05-25T23:58:21Z |
dc.date.available.none.fl_str_mv |
2020-05-25T23:58:21Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.arbres.2017.04.012 |
dc.identifier.issn.none.fl_str_mv |
3002896 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/22844 |
url |
https://doi.org/10.1016/j.arbres.2017.04.012 https://repository.urosario.edu.co/handle/10336/22844 |
identifier_str_mv |
3002896 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
628 |
dc.relation.citationIssue.none.fl_str_mv |
No. 11 |
dc.relation.citationStartPage.none.fl_str_mv |
622 |
dc.relation.citationTitle.none.fl_str_mv |
Archivos de Bronconeumologia |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 53 |
dc.relation.ispartof.spa.fl_str_mv |
Archivos de Bronconeumologia, ISSN:3002896, Vol.53, No.11 (2017); pp. 622-628 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044788291&doi=10.1016%2fj.arbres.2017.04.012&partnerID=40&md5=1a73c119424c3fc87652814daeea1b5e |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Elsevier Doyma |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167644202336256 |